Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice
Preprint
- 18 May 2021
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
The COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus, has triggered a worldwide health emergency. So far, several different types of vaccines have shown strong efficacy. However, both the emergence of new SARS-CoV-2 variants and the need to vaccinate a large fraction of the world’s population necessitate the development of alternative vaccines, especially those that are simple and easy to store, transport and administer. Here, we showed that ferritin-like Dps protein from hyperthermophilic Sulfolobus islandicus can be covalently coupled with different SARS-CoV-2 antigens via the SpyCatcher system, to form extremely stable and defined multivalent dodecameric vaccine nanoparticles that remain intact even after lyophilisation. Immunisation experiments in mice demonstrated that the SARS-CoV-2 receptor binding domain (RBD) coupled to Dps (RBD-S-Dps) shows particular promise as it elicited a higher antibody titre and an enhanced neutralising antibody response compared to the monomeric RBD. Furthermore, we showed that a single immunisation with the multivalent RBD-S-Dps completely protected hACE2-expressing mice from serious illness and led to efficient viral clearance from the lungs upon SARS-CoV-2 infection. Our data highlight that multimerised SARS-CoV-2 subunit vaccines are a highly efficacious modality, particularly when combined with an ultra-stable scaffold.Keywords
Other Versions
- Published version: Version FEBS Letters, 595, preprints
This publication has 54 references indexed in Scilit:
- Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamstersPublished by Cold Spring Harbor Laboratory ,2021
- Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in miceScience, 2021
- T cell responses in patients with COVID-19Nature Reviews Immunology, 2020
- Clinical trials for COVID-19 should include sex as a variableJCI Insight, 2020
- TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccinationProceedings of the National Academy of Sciences of the United States of America, 2018
- Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display VaccinationACS Nano, 2018
- New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and GlueFrontiers in Immunology, 2018
- Initiation of T cell signaling by CD45 segregation at 'close contacts'Nature Immunology, 2016
- Glycan Remodeling with Processing Inhibitors and Lectin-Resistant Eukaryotic CellsMethods in Molecular Biology, 2015
- A time- and cost-efficient system for high-level protein production in mammalian cellsActa crystallographica. Section D, Structural biology, 2006